170 related articles for article (PubMed ID: 36533564)
1. 4-O-Substituted Glucuronic Cyclophellitols are Selective Mechanism-Based Heparanase Inhibitors.
Borlandelli V; Armstrong Z; Nin-Hill A; Codée JDC; Raich L; Artola M; Rovira C; Davies GJ; Overkleeft HS
ChemMedChem; 2023 Feb; 18(4):e202200580. PubMed ID: 36533564
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity and structure-activity relationship of heparanase inhibitors: Recent advances.
Fu K; Bai Z; Chen L; Ye W; Wang M; Hu J; Liu C; Zhou W
Eur J Med Chem; 2020 May; 193():112221. PubMed ID: 32222663
[TBL] [Abstract][Full Text] [Related]
3. Chemical toolbox to interrogate Heparanase-1 activity.
Rabinowitz ZM; Somers J; Wang Z; Cui L
Curr Opin Chem Biol; 2024 Jun; 80():102452. PubMed ID: 38555836
[TBL] [Abstract][Full Text] [Related]
4. An Overview of the Structure, Mechanism and Specificity of Human Heparanase.
Wu L; Davies GJ
Adv Exp Med Biol; 2020; 1221():139-167. PubMed ID: 32274709
[TBL] [Abstract][Full Text] [Related]
5. Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo.
de Boer C; Armstrong Z; Lit VAJ; Barash U; Ruijgrok G; Boyango I; Weitzenberg MM; Schröder SP; Sarris AJC; Meeuwenoord NJ; Bule P; Kayal Y; Ilan N; Codée JDC; Vlodavsky I; Overkleeft HS; Davies GJ; Wu L
Proc Natl Acad Sci U S A; 2022 Aug; 119(31):e2203167119. PubMed ID: 35881786
[TBL] [Abstract][Full Text] [Related]
6. Structural characterization of human heparanase reveals insights into substrate recognition.
Wu L; Viola CM; Brzozowski AM; Davies GJ
Nat Struct Mol Biol; 2015 Dec; 22(12):1016-22. PubMed ID: 26575439
[TBL] [Abstract][Full Text] [Related]
7. Discovery and development of small-molecule heparanase inhibitors.
Zhang Y; Cui L
Bioorg Med Chem; 2023 Jul; 90():117335. PubMed ID: 37257254
[TBL] [Abstract][Full Text] [Related]
8. Complex Inhibitory Mechanism of Glycomimetics with Heparanase.
Whitefield C; Vo Y; Schwartz BD; Hepburn C; Ahmed FH; Onagi H; Banwell MG; Nelms K; Malins LR; Jackson CJ
Biochemistry; 2023 Jul; 62(14):2202-2215. PubMed ID: 37368361
[TBL] [Abstract][Full Text] [Related]
9. Potential roles of heparanase in cancer therapy: Current trends and future direction.
Yang Y; Yuan F; Zhou H; Quan J; Liu C; Wang Y; Xiao F; Liu Q; Liu J; Zhang Y; Yu X
J Cell Physiol; 2023 May; 238(5):896-917. PubMed ID: 36924082
[TBL] [Abstract][Full Text] [Related]
10. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
[TBL] [Abstract][Full Text] [Related]
11. Heparanase Inhibitors in Cancer Progression: Recent Advances.
Kaur R; Deb PK; Diwan V; Saini B
Curr Pharm Des; 2021; 27(1):43-68. PubMed ID: 33185156
[TBL] [Abstract][Full Text] [Related]
12. Heparanase mediates a novel mechanism in lapatinib-resistant brain metastatic breast cancer.
Zhang L; Ngo JA; Wetzel MD; Marchetti D
Neoplasia; 2015 Jan; 17(1):101-13. PubMed ID: 25622903
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
Naggi A; Casu B; Perez M; Torri G; Cassinelli G; Penco S; Pisano C; Giannini G; Ishai-Michaeli R; Vlodavsky I
J Biol Chem; 2005 Apr; 280(13):12103-13. PubMed ID: 15647251
[TBL] [Abstract][Full Text] [Related]
14. A Marine λ-Oligocarrageenan Inhibits Migratory and Invasive Ability of MDA-MB-231 Human Breast Cancer Cells through Actions on Heparanase Metabolism and MMP-14/MMP-2 Axis.
Cousin R; Groult H; Manseur C; Ferru-Clément R; Gani M; Havret R; Toucheteau C; Prunier G; Colin B; Morel F; Piot JM; Lanneluc I; Baranger K; Maugard T; Fruitier-Arnaudin I
Mar Drugs; 2021 Sep; 19(10):. PubMed ID: 34677445
[TBL] [Abstract][Full Text] [Related]
15. Decidual heparanase activity is increased during pregnancy in the baboon (Papio anubis) and in in vitro decidualization of human stromal cells.
D'Souza SS; Fazleabas AT; Banerjee P; Sherwin JR; Sharkey AM; Farach-Carson MC; Carson DD
Biol Reprod; 2008 Feb; 78(2):316-23. PubMed ID: 17989358
[TBL] [Abstract][Full Text] [Related]
16. Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity.
Yang Y; Gorzelanny C; Bauer AT; Halter N; Komljenovic D; Bäuerle T; Borsig L; Roblek M; Schneider SW
Oncogene; 2015 Nov; 34(47):5832-42. PubMed ID: 25745999
[TBL] [Abstract][Full Text] [Related]
17. A Universal and Modular Scaffold for Heparanase Activatable Probes and Drugs.
Schleyer KA; Liu J; Chen Z; Wang Z; Zhang Y; Zuo J; Ybargollin AJ; Guo H; Cui L
Bioconjug Chem; 2022 Dec; 33(12):2290-2298. PubMed ID: 36346913
[TBL] [Abstract][Full Text] [Related]
18. Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies.
Ostrovsky O; Korostishevsky M; Levite I; Leiba M; Galski H; Vlodavsky I; Nagler A
Leukemia; 2007 Nov; 21(11):2296-303. PubMed ID: 17611567
[TBL] [Abstract][Full Text] [Related]
19. Non-reducing end labeling of heparan sulfate via click chemistry and a high throughput ELISA assay for heparanase.
Wu ZL; Huang X; Ethen CM; Tatge T; Pasek M; Zaia J
Glycobiology; 2017 Jun; 27(6):518-524. PubMed ID: 28025251
[TBL] [Abstract][Full Text] [Related]
20. Activity-based probes for functional interrogation of retaining β-glucuronidases.
Wu L; Jiang J; Jin Y; Kallemeijn WW; Kuo CL; Artola M; Dai W; van Elk C; van Eijk M; van der Marel GA; Codée JDC; Florea BI; Aerts JMFG; Overkleeft HS; Davies GJ
Nat Chem Biol; 2017 Aug; 13(8):867-873. PubMed ID: 28581485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
